AI-assisted Microscope Improved the Precision of HER2 IHC 0 and 1+of Breast Cancer

被引:0
|
作者
Yue, Meng [1 ]
Wang, Xinran [1 ]
Liu, Yueping [1 ]
机构
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
197
引用
收藏
页码:217 / 218
页数:2
相关论文
共 50 条
  • [1] AI-assisted Microscope Improved the Precision of HER2 IHC 0 and 1+of Breast Cancer
    Yue, Meng
    Wang, Xinran
    Liu, Yueping
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 217 - 218
  • [2] Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study
    Meng Yue
    Jun Zhang
    Xinran Wang
    Kezhou Yan
    Lijing Cai
    Kuan Tian
    Shuyao Niu
    Xiao Han
    Yongqiang Yu
    Junzhou Huang
    Dandan Han
    Jianhua Yao
    Yueping Liu
    [J]. Virchows Archiv, 2021, 479 : 443 - 449
  • [3] Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study
    Yue, Meng
    Zhang, Jun
    Wang, Xinran
    Yan, Kezhou
    Cai, Lijing
    Tian, Kuan
    Niu, Shuyao
    Han, Xiao
    Yu, Yongqiang
    Huang, Junzhou
    Han, Dandan
    Yao, Jianhua
    Liu, Yueping
    [J]. VIRCHOWS ARCHIV, 2021, 479 (03) : 443 - 449
  • [4] Interobserver Agreement in HER2 IHC 0 and IHC1+in Breast Cancer and its Concordance with HER2 AI Solution: A Retrospective Multi-Institutional Study from 10 Centers in China
    Lv, Hong
    Yang, Haifeng
    Zhang, Qingfu
    Xu, Fangping
    Gao, Peng
    Nie, Xiu
    Yue, Junqiu
    Zhang, Guanjun
    Kong, Lingfei
    Li, Jianming
    Yang, Wentao
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S218 - S218
  • [5] Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer
    Johnston, Laura E.
    Randall, Jamie
    Chouraichi, Safae
    Luu, Mary
    Hunt, Allison L.
    Mauro, Lauren
    Mueller, Claudius
    Davis, Justin B.
    Petricoin, Emanuel F.
    Conrads, Thomas P.
    Cannon, Timothy L.
    Huynh, Jasmine
    [J]. NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [6] The Advantage of Artificial-Intelligence in HER2 IHC 0 and 1+Scoring in Breast Cancer
    Li, Ming
    Lv, Hong
    Zhao, Yizhi
    Zhu, Chenglu
    Li, Hansheng
    Lin, Mingzhen
    Yang, Wen-Tao
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [7] Novel Quantitative HER2 Assay for Determining Dynamic HER2 Expression in the HER2 IHC 0 "Ultra-Low" Setting: Implications for Precision Therapy in HER2-Breast Cancer
    Petricoin, Emanuel F.
    Corgiat, Brian A.
    O'Shaughnessy, Joyce
    LoRusso, Patricia
    Weinberg, Kris
    Davis, Justin
    Gawryletz, Chelsea
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [8] Breast Cancer with Equivocal HER2 IHC: Does HER2 IHC Intensity Identify Areas with FISH Amplification?
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen
    O'Connor, Siobhan
    Calhoun, Benjamin
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 173 - 173
  • [9] Breast Cancer with Equivocal HER2 IHC: Does HER2 IHC Intensity Identify Areas with FISH Amplification?
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen
    O'Connor, Siobhan
    Calhoun, Benjamin
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 173 - 173
  • [10] Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer
    Xiong, Zhongtang
    Liu, Kai
    Liu, Shaoyan
    Feng, Jiahao
    Wang, Jin
    Feng, Zewen
    Lai, Boan
    Zhang, Qingxin
    Jiang, Qingping
    Zhang, Wei
    [J]. BMC CANCER, 2024, 24 (01)